Clinical TrialsSearch results
Number of results: 708
Other
- Comparative study of neoadjuvant MVAC chemotharapy plus radical systectomy with radical cystectomy alone for imparovent of survival of patients with invasive bladder cancer (T2-4aN0M0)(JCOG0209, BC MVAC Phase III)
- T2-T4aN0M0 invasive bladder cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- A phase II study of stereotactic body radiation therapy in patients with T1N0M0 non-small cell lung cancer (JCOG0403)
- T1N0M0 non-small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-28
Other
- Phase II study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-07-05
Other
- A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II/III study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-03-16
Other
- Mizolibin for systemic lupus erythematosus in children(JSRDC10)
- systematic lupus erythematosus
- Japanese Study Group of Renal Disease in Children(JSRDC)
- 2006-04-01
Other
- A combination of methylprednisolone and prednisolone and a combination of Methylprednisolone, prednisolone and mizoribine for systemic lupus erythematosus in children: A randomized controlled trial of efficacy and safety izolibin for (JSRDC04)
- systematic lupus erythematosus
- Japanese Study Group of Renal Disease in Children(JSRDC)
- 2006-04-01
Other
- Mavacamten in non-obstructive HCM
- symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM)
- Aronson Ron
- 2023-02-23
Other
- A phase I/II study of percutaneous radiofrequency ablation for malignant tumor in the pelvis (JIVROSG-0204)
- Symptomatic intrapelvic malignant tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- Japanese Extracranial-Intracranial Arterial Bypass Trial
- Symptomatic internal carotid artery or middle cerebral artery occlusion or stenosis
- JET Study Group
- 2005-09-08
Other
- A study to evaluate efficacy and safety of Valganciclovir in patients with cytomegalovirus disease.
- Symptomatic congenital cytomegalovirus infection
- Nozu Kandai
- 2019-11-15